In recently posted U.S. Food and Drug Administration (FDA) warning letters, three producers were cited for holding animals “under conditions that are so inadequate that medicated animals bearing potentially harmful drug residues are likely to enter the food supply.” Papas Dairy of North Bangor, NY, was cited for illegal drug residue in a calf sold for slaughter. David T. Phillips’ beef-raising operation in Midway, KY, was cited for oxytetracycline, florfenicol, ciprofloxacin and flunixin residues in the tissue samples of a bull transported for slaughter. And FDA stated that Neely Livestock in Murfreesboro, TN, sold a pig for slaughter that had penicillin in its muscle and kidney tissues and spectinomycin residue in its kidney tissue. FDA has established a tolerance of 0.0 ppm for penicillin residues. A seafood-processing facility in Lynn, MA, was found to have a “a serious violation” of the seafood Hazard Analysis and Critical Control Point (HACCP) regulations. On July 30, an FDA investigator saw Kettle Cuisine employees cut open underweight or defective finished containers of Manhattan clam chowder and add them back into the holding tank, the letter stated. In an August response to the agency, the company indicated that it has stopped this practice. FDA warned that the company’s response “did not address our observation related to not identifying the food safety hazard of pathogenic bacteria introduction after cooking that is reasonably likely to occur at the hot filling, container sealing, and container cooling steps.” Grandmas Food Products in Muvattupuzha, Kerala, India, failed to establish scheduled processes of its acidified foods in accordance with regulations, FDA stated. In addition, the agency said that plant personnel in acidification, pH control, heat treatment, or other critical factors of the operation are not under the operating supervision of a person who has attended a school approved by the agency. Burnette Foods of East Jordan, MI, also faced “serious violations” of the regulations for acidified foods, including deviations from filed scheduled process for its Shelf Stable Hummus. Rongcheng Shidao Guangxin Food Co.’s low-acid canned seafood processing facility in Rongcheng, China, was cited for serious violations of low-acid canned food regulations. Issues included some missing details in the scheduled process for sardines in oil, failing to maintain proper records, and failing to check container handling equipment frequently to prevent damage. FDA also considered the company’s Hyper Harbor brand for Sardines in Tomato Sauce with Chili and Sardines in Brine misbranded because they failed to declare the acceptable market name for the fish used on the label’s list of ingredients. Lastly, a review of the label and website for Artisana Coconut Butter Whole Coconut Flesh produced by Premier Organics of Oakland, CA, led FDA to consider the product misbranded because the label bears “nutrient content claims but do not meet the requirements to make the claims.” FDA explained that the label reads “The Art of Healthy Foods” and “healthy…food…” in connection with the statement “preserves the life-essential fatty acids, enzymes, vitamins and minerals,” but that the coconut butter doesn’t meet the requirements for use of the nutrient content claim “healthy.” Each company was given 15 days to respond to the concerns raised by FDA in the warning letters.